柯诺CARENOVO品牌怎么样 申请店铺

我要投票 柯诺CARENOVO在血糖仪行业中的票数:575 更新时间:2026-01-09
柯诺CARENOVO是哪个国家的品牌?「柯诺CARENOVO」是 珠海柯诺医疗科技有限公司 旗下著名品牌。该品牌发源于广东省珠海市,由创始人洪 *在2012年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力柯诺CARENOVO品牌出海!将品牌入驻外推网,定制柯诺CARENOVO品牌推广信息,可以显著提高柯诺CARENOVO产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

柯诺CARENOVO怎么样

珠海柯诺医疗科技有限公司,座落于中国浪漫之都——珠海,是一家立足慢病防控领域,从事相关医疗设备、诊断试剂研发、制造及销售,具有可持续发展实力的生物医疗高科技企业。

公司成立至今,一直专注于人类健康事业的发展,专注于打造互联网慢病防控生态圈。在不断完善“无痛无感染激光采血+即时(POCT)慢病检测分析”等产业链相关产品的基础上,注重将差异化、人性化的快检产品与移动互联网、穿戴医疗、大数据等相结合,服务于国内外各大医疗机构,并借助与移动运营商、平台商的合作,加速惠及千家万户,打造慢病检测监控完整的”医院—社区—家庭“健康管理链条。

公司重视科技创新,拥有一支高技术水平的研发团队,设有十万级超净化车间,并在武汉光谷拥有研发中心,建立了成熟的电化学快检技术平台、量子点荧光免疫技术平台、激光无痛采血技术平台,能结合不同客户需求,量身定制个性化的慢病系统整体解决方案。

目前,公司在全国各大区已设有营销办事处,能为客户提供便捷的服务。销量高的产品涵盖血糖监测、无痛激光采血、感染控制三大系列,随着公司的不断发展突破,还将陆续推出尿酸分析仪、血脂分析仪、多功能家庭健康礼盒、PDA血糖仪、医用激光采血仪等一批具有国际水平的产品。


Zhuhai Kono Medical Technology Co., Ltd., located in Zhuhai, the romantic capital of China, is a biomedical high-tech enterprise with sustainable development strength, which is based on the field of chronic disease prevention and control, engaged in the research and development, manufacturing and sales of relevant medical equipment and diagnostic reagents. Since its establishment, the company has been focusing on the development of human health, focusing on building an Internet slow disease prevention and control ecosystem. Based on the continuous improvement of "painless and infection free laser blood collection + instant (POCT) chronic disease detection and analysis" and other industry chain related products, we focus on the combination of differentiated and humanized rapid detection products with mobile Internet, wearable medicine, big data, etc. to serve major medical institutions at home and abroad, and with the help of cooperation with mobile operators and platform providers, we will accelerate the benefits to thousands of households and fight A complete "hospital community family" health management chain for chronic disease detection and monitoring. The company attaches great importance to scientific and technological innovation, has a high-tech R & D team, a 100000 level super purification workshop, and a R & D center in Wuhan Optical Valley, and has established a mature electrochemical rapid detection technology platform, quantum dot fluorescence immune technology platform, laser painless blood collection technology platform, which can combine different customer needs to customize personalized overall solutions for chronic disease system. At present, the company has set up marketing offices in various regions of the country, which can provide convenient services for customers. The products with high sales volume cover three series of blood glucose monitoring, painless laser blood sampling and infection control. With the continuous development and breakthrough of the company, a number of products with international level, such as uric acid analyzer, blood lipid analyzer, multifunctional family health gift box, PDA blood glucose meter and medical laser blood sampler, will be successively launched.

本文链接: https://brand.waitui.com/bdaf7fa61.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

福建铁路公司注册资本增至377.1亿,增幅约15%

36氪获悉,爱企查App显示,近日,福建铁路有限公司发生工商变更,注册资本由约328.1亿人民币增至约377.1亿人民币,增幅约15%。

2小时前

日联科技:已完成收购SSTI 66%股权

36氪获悉,日联科技公告,公司全资子公司新加坡瑞泰已按照协议约定支付本次交易的股权收购款,并取得 SSTI 66%股权,本次股权交割已完成。

2小时前

正海生物:公司取得医疗器械注册证

36氪获悉,正海生物公告,公司于近日取得国家药品监督管理局下发的《中华人民共和国医疗器械注册证》,产品名称为钙硅生物陶瓷口腔骨修复材料,注册证编号为国械注准20263170015,有效期至2031年1月6日。该产品适用于牙槽骨缺损修复,采用三维打印方式成型,具备定制化生产潜力。此注册证的取得将丰富公司口腔领域产品线,提升市场竞争力。但产品上市后实际销售情况取决于市场推广效果,对公司未来业绩的影响无法准确预测。

2小时前

闲鱼:2025年二次元、追星与游戏用户总量已突破1.6亿

36氪获悉,《2025闲鱼次元年度报告》显示,截至2025年底,闲鱼二次元、追星与游戏用户总量已突破1.6亿,年度二次元消费人数同比增长47%,平台已成为年轻人兴趣消费的首选阵地。

2小时前

绿地控股:预计2025年净亏损160亿元-190亿元

36氪获悉,绿地控股公告,预计2025年归属于母公司所有者的净利润为-190亿元到-160亿元。上年同期为-155.52亿元。受资产价格持续下行、公司加大促销去化力度、部分项目开发周期延长等多种因素的影响,基于谨慎性原则,公司对存在风险的存货拟计提减值准备;由于市场有效需求不足、社会预期偏弱,公司房地产业的结转规模、基建产业的营收规模同比均有较大幅度的下降,公司房地产业结转毛利率也同比下降,导致业绩进一步承压;房地产项目利息资本化减少,计入当期财务费用的利息支出增加。

2小时前

本页详细列出关于柯诺CARENOVO的品牌信息,含品牌所属公司介绍,柯诺CARENOVO所处行业的品牌地位及优势。
咨询